Search clinical trials for: immunosuppressive switch (to Certican)

Total 16131 results

University of Nebraska
Genzyme, a Sanofi Company

Unknown

A Study of Thymoglobulin and Tacrolimus in Liver Transplant (thymo)

Liver Transplantation | Liver Disease | Immunosuppression

United States
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Completed

Phase II Study Using Thalidomide for the Treatment of ALS

Amyotrophic Lateral Sclerosis | ALS

United States
Keio University

Terminated

Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

Japan
Eli Lilly and Company

Completed

Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes

Metastatic Breast Cancer

Saudi Arabia
Hoffmann-La Roche

Terminated

A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.

Kidney Transplantation

Germany
Mast Therapeutics, Inc.

Unknown

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Metastatic Colorectal Cancer | Rectal Cancer | Colon Cancer

United States, Former Serbia and Montenegro
Ministry of Scientific Research and Information...

Terminated

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Esophageal Neoplasms | Squamous Cell Cancer

Poland
University of Saskatchewan

Completed

Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC

Non Small Cell Lung Cancer

Canada
Eli Lilly and Company

Completed

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
University Hospital, Limoges
Groupe Français de Pneumologie Cancérologie (GFPC)

Completed

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

France
Gruppo Italiano Multiregionale per lo studio dei...

Completed

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B-Cell Lymphoma | POOR PROGNOSIS

Italy
Belgian Inflammatory Bowel Disease Research and...
Schering-Plough; Centocor BV

Completed

Top Down Versus Step Up Strategies in Crohn's Disease

Crohn's Disease

Belgium
Azad University of Medical Sciences

Terminated

Comparison of Two Combined Therapeutic Methods for Treatment of Lateral Epicondylitis

Lateral Epicondylitis

Iran, Islamic Republic of
Novacea
Schering-Plough

Suspended

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Eli Lilly and Company

Completed

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Fudan University

Unknown

Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

Hepatocellular Carcinoma

China
Eli Lilly and Company

Completed

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell-Lung Cancer

Turkey
InterMune

Terminated

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

Pulmonary Fibrosis | Lung Disease

Italy
Eli Lilly and Company

Completed

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Urologic Neoplasms | Carcinoma, Transitional Cell

Japan
Southwestern Regional Medical Center

Terminated

ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

United States
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Suspended

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

Japan
Korea University Anam Hospital
Seoul National University Hospital; Seoul National University Bundang Hospital and other collaborators

Completed

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

Neoplasm Metastasis | Pancreatic Neoplasm

Korea, Republic of
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Suspended

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Japan
Kentuckiana Cancer Institute

Completed

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Gruppo Italiano MEsotelioma

Unknown

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Mesothelioma

Italy
Sirion Therapeutics, Inc.

Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Dry Eye Syndromes

United States
Northwell Health
The Cleveland Clinic; University of North Carolina

Completed

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

Focal Glomerulosclerosis

United States
Eli Lilly and Company

Completed

Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

Pancreatic Neoplasms

France
Université Catholique de Louvain

Completed

A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study

Rheumatoid Arthritis

Belgium
Johann Wolfgang Goethe University Hospital

Unknown

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Philadelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid Leukemia

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Etanercept

Rheumatoid Arthritis
Uniwersytet Mikolaja Kopernika w Toruniu
Astellas Pharma Inc

Unknown

Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

Kidney Transplantation

Poland
Cordis Corporation

Completed

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Coronary Artery Disease

Netherlands
Cordis Corporation

Completed

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Coronary Artery Disease

Brazil
Swedish Medical Center
Novartis

Completed

Phase II Trial of RAD001 in Refractory Colorectal Cancer

Colorectal Cancer

United States
Hospices Civils de Lyon

Unknown

WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides

Systemic Wegener's Granulomatosis

France
Genovate Biotechnology Co., Ltd.,

Completed

Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

Type 2 Diabetes Mellitus

Taiwan
Abbott

Completed

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

Rheumatoid Arthritis
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Connective Tissue Oncology Society; Massachusetts... and other collaborators

Completed

Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
Herlev Hospital
Eli Lilly and Company; Sanofi

Completed

Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

Prostate Cancer

Denmark
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Adult ALL Treatment at Diagnosis (LAL2000)

Leukemia, Lymphocytic, Acute

Italy
Cooperative Study Group A for Hematology

Unknown

Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML

Acute Myeloid Leukemia

Korea, Republic of
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Neuroectodermal Tumors, Primitive | Medulloblastoma | Brain Tumors

France
University Heart Center Freiburg - Bad Krozingen
Cordis, Johnson&Johnson company

Unknown

Treatment of Bifurcated Coronary Lesions With Cypher™-Stent

Coronary Artery Disease

Germany
Saitama Medical University

Completed

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Cardiovascular Disease
Eli Lilly and Company

Completed

A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease

Breast Cancer | Breast Neoplasms | Cancer of the Breast

United States
Heinrich-Heine University, Duesseldorf

Completed

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Cutaneous Lupus Erythematosus

Germany
University of Oslo School of Pharmacy

Completed

Metabolic Pattern of Cyclosporine A and Acute Renal Failure

Heart Transplantation | Acute Renal Failure

Norway
Faculdade de Medicina do ABC

Unknown

Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain

Pain | Cancer | Palliative Care

Brazil
Fudan University

Unknown

Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer

Breast Neoplasms | Chemotherapy | Adjuvant

China

Search clinical trials for: immunosuppressive switch (to Certican)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations